Chronic Obstructive Pulmonary Disease (COPD) Market is Expected to Expand at a Healthy Growth Rate During the Forecast Period (2022-2032), States DelveInsight | Key Companies – sanofi, regeneron, verona pharma, AstraZeneca,Mereo biopharma
DelveInsight’s “Chronic Obstructive Pulmonary Disease Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Chronic Obstructive Pulmonary Disease , historical and forecasted epidemiology as well as the Chronic Obstructive Pulmonary Disease market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Chronic Obstructive Pulmonary Disease Overview
Chronic Obstructive Pulmonary Disease is a preventable, treatable and common disease characterized by persistent respiratory symptoms and airflow limitation due to airway and/or alveolar abnormalities usually caused by significant exposure to noxious particles or gasses. The main risk factor of Chronic Obstructive Pulmonary Disease is tobacco smoking, but other environmental exposures such as biomass fuel exposure and air pollution may contribute.
Some of the key facts of the Chronic Obstructive Pulmonary Disease Market Report:
• The Chronic Obstructive Pulmonary Disease market is anticipated to grow with a significant CAGR for the study period 2019-32.
• In recent years, Chronic Obstructive Pulmonary Disease diagnosis was around 34,000,000 cases.
• Chronic Obstructive Pulmonary Disease epidemiology based on gender analyzed that Chronic Obstructive Pulmonary Disease diagnosis is more common in females as compared to males in the 7MM.
• Chronic Obstructive Pulmonary Disease emerging therapies like Itepekimab (SAR440340/REGN3500/Anti-IL-33 mAb), Ensifentrine (RPL554), Dupixent (dupilumab), Fasenra (benralizumab), Nucala (Mepolizumab), Acumapimod (BCT-197) are expected to change the dynamics of the Chronic Obstructive Pulmonary Disease market.
• Chronic Obstructive Pulmonary Disease prevalence is increasing drastically due to the higher smoking prevalence.
• Low cost and less time consuming Chronic Obstructive Pulmonary Disease therapies are required in the Chronic Obstructive Pulmonary Disease market.
Request a sample for the Chronic Obstructive Pulmonary Disease Market Report
Key benefits of the Chronic Obstructive Pulmonary Disease Market report:
1. Chronic Obstructive Pulmonary Disease market report covers a descriptive overview and comprehensive insight of the Chronic Obstructive Pulmonary Disease Epidemiology and Chronic Obstructive Pulmonary Disease market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)
2. The Chronic Obstructive Pulmonary Disease market report provides insights on the current and emerging therapies.
3. Chronic Obstructive Pulmonary Disease market report provides a global historical and forecasted market covering drug outreach in 7MM.
4. The Chronic Obstructive Pulmonary Disease market report offers an edge that will help develop business strategies by understanding trends shaping and driving the Chronic Obstructive Pulmonary Disease market.
Got queries? Click here to know more about the Chronic Obstructive Pulmonary Disease Market Landscape
Epidemiology Segmentation of Chronic Obstructive Pulmonary Disease :
• Prevalent Cases of Chronic Obstructive Pulmonary Disease in the 7MM [2019-2032]
• Age-Specific Cases of Chronic Obstructive Pulmonary Disease in the 7MM [2019–2032]
• Gender-Specific Cases of Chronic Obstructive Pulmonary Disease in the 7MM [2019–2032]
• Diagnosed and Treated Cases of Chronic Obstructive Pulmonary Disease in the 7MM [2019–2032]
Chronic Obstructive Pulmonary Disease Market
The dynamics of the Chronic Obstructive Pulmonary Disease market are anticipated to change in the coming years owing to the expected launch of emerging therapies, and others during the forecasted period 2019-2032.
Chronic Obstructive Pulmonary Disease Market Drivers
• Increasing Chronic Obstructive Pulmonary Disease prevalence
• Chronic Obstructive Pulmonary Disease emerging therapies development
• Personalized Chronic Obstructive Pulmonary Disease treatment
• Entry of ‘act earlier’ in the Chronic Obstructive Pulmonary Disease market.
• Improvement in Chronic Obstructive Pulmonary Disease diagnostic techniques.
• Growing demand for Chronic Obstructive Pulmonary Disease fixed- dose combinations.
Chronic Obstructive Pulmonary Disease Market Barriers
• Late Chronic Obstructive Pulmonary Disease recognition.
• High cost of Chronic Obstructive Pulmonary Disease treatment
• Challenges in existing Chronic Obstructive Pulmonary Disease treatments
• Patient-related Chronic Obstructive Pulmonary Disease barriers
• Chronic Obstructive Pulmonary Disease drug failure
• Availability of generics
Chronic Obstructive Pulmonary Disease Unmet Needs
• Immense need for more targeted and holistic management of the Chronic Obstructive Pulmonary Disease
• Techniques are required for managing heterogeneity of the Chronic Obstructive Pulmonary Disease
• Chronic Obstructive Pulmonary Disease education and awareness.
Learn more by requesting for sample @ Chronic Obstructive Pulmonary Disease Market Landscape
Chronic Obstructive Pulmonary Disease Pipeline Therapies and Key Companies
• Itepekimab (SAR440340/REGN3500/Anti-IL-33 mAb): Sanofi/Regeneron Pharmaceuticals
• Ensifentrine (RPL554): Verona Pharma plc.
• Dupixent (dupilumab): Regeneron Pharmaceuticals/ Sanofi
• Fasenra (benralizumab): AstraZeneca
• Nucala (Mepolizumab): GlaxoSmithKline
• Acumapimod (BCT-197): Mereo BioPharma
Table of Contents
1. Chronic Obstructive Pulmonary Disease Market Report Introduction
2. Executive Summary for Chronic Obstructive Pulmonary Disease
3. SWOT analysis of Chronic Obstructive Pulmonary Disease
4. Chronic Obstructive Pulmonary Disease Patient Share (%) Overview at a Glance
5. Chronic Obstructive Pulmonary Disease Market Overview at a Glance
6. Chronic Obstructive Pulmonary Disease Disease Background and Overview
7. Chronic Obstructive Pulmonary Disease Epidemiology and Patient Population
8. Country-Specific Patient Population of Chronic Obstructive Pulmonary Disease
9. Chronic Obstructive Pulmonary Disease Current Treatment and Medical Practices
10. Chronic Obstructive Pulmonary Disease Unmet Needs
11. Chronic Obstructive Pulmonary Disease Emerging Therapies
12. Chronic Obstructive Pulmonary Disease Market Outlook
13. Country-Wise Chronic Obstructive Pulmonary Disease Market Analysis (2019–2032)
14. Chronic Obstructive Pulmonary Disease Market Access and Reimbursement of Therapies
15. Chronic Obstructive Pulmonary Disease Market drivers
16. Chronic Obstructive Pulmonary Disease Market barriers
17. Chronic Obstructive Pulmonary Disease Appendix
18. Chronic Obstructive Pulmonary Disease Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
Click here to read more about Chronic Obstructive Pulmonary Disease Market Outlook 2032
Related Reports:
Chronic Obstructive Pulmonary Disease Pipeline
“Chronic Obstructive Pulmonary Disease Pipeline Insight, 2023“ report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Chronic Obstructive Pulmonary Disease market. A detailed picture of the Chronic Obstructive Pulmonary Disease pipeline landscape is provided, which includes the disease overview and Chronic Obstructive Pulmonary Disease treatment guidelines.
Chronic Obstructive Pulmonary Disease Epidemiology
DelveInsight’s ‘Chronic Obstructive Pulmonary Disease Epidemiology Forecast to 2032‘ report delivers an in-depth understanding of the disease, historical and forecasted Chronic Obstructive Pulmonary Disease epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Navdha Goel
Email: info@delveinsight.com
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com
